Treatment | BEI | % of Control | CLbile | % of Control |
---|---|---|---|---|
% | ml/min/kg | |||
Control | 11.1 ± 1.1 | 100 | 1.81 ± 0.32 | 100 |
PB(0.2 mM) | 18.2 ± 0.8* | 164 | 3.08 ± 0.02* | 170 |
PB(0.5 mM) | 33.5 ± 0.7** | 301 | 5.31 ± 0.53** | 293 |
PB(1 mM) | 41.4 ± 1.1** | 372 | 6.27 ± 1.03** | 346 |
Control | 14.6 ± 0.3 | 100 | 1.12 ± 0.19 | 100 |
H2O2(0.1 mM) | 24.6 ± 1.7 | 168 | 1.42 ± 0.25 | 127 |
H2O2(0.25 mM) | 40.4 ± 1.4* | 276 | 2.17 ± 0.95* | 194 |
H2O2(0.5 mM) | 46.6 ± 1.8** | 319 | 3.06 ± 0.65** | 273 |
Control | 13.7 ± 0.5 | 100 | 1.22 ± 0.62 | 100 |
Quercetin(2 µM) | 32.6 ± 3.0* | 237 | 1.94 ± 2.41* | 159 |
Quercetin(10 µM) | 43.0 ± 3.8** | 313 | 2.95 ± 0.00** | 242 |
Quercetin(20 µM) | 63.3 ± 0.6** | 461 | 3.41 ± 0.88** | 280 |
* P ≤ 0.05 and **P ≤ 0.01 indicate statistically significant differences when compared with the control group without inhibitor.